NRC Health
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M | $133.3M | $128.0M | $119.7M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $54.8M | $44.9M | $46.6M | $42.7M | $39.0M | $34.4M | $33.0M | $31.4M |
| Operating Income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M | $42.7M | $43.0M | $35.3M |
| Operating Margin | 16.4% | 24.6% | 27.0% | 30.7% | 34.0% | 32.0% | 33.6% | 29.5% |
| Interest Expense | — | $2.6M | $862.0K | $1.2M | $1.7M | $1.8M | $2.1M | $1.5M |
| Pretax Income | $17.8M | $32.7M | $40.0M | $42.8M | $48.6M | $41.5M | $40.5M | $34.7M |
| Income Tax Expense | $6.2M | $7.9M | $9.0M | $11.0M | $11.2M | $4.2M | $8.1M | $4.7M |
| Net Income | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M | $37.3M | $32.4M | $30.0M |
| Net Margin | 8.4% | 17.3% | 20.8% | 21.0% | 25.3% | 28.0% | 25.3% | 25.1% |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | — |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | — |
| Shares Outstanding (Basic) | 22.4M | 23.7M | 24.5M | 24.9M | 25.4M | 25.2M | 24.8M | 24.8M |
| Shares Outstanding (Diluted) | 22.4M | 23.7M | 24.7M | 25.1M | 25.6M | 25.7M | 25.7M | 24.8M |
| Dividends Per Share | $0.52 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | — |